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ABSTRACT
Nineteen compounds has been isolated from the 80% methanolic extract of Kankyo (Japanese name 
for Zingiberis processum rhizome) made out of ginger, including a glucoside of 6－gingerdiol (15), four 
diarylheptanoids (16 – 19) and the sulfonated compounds such as 6－gingesulfonic acid (10) and shogasulfonic 
acid A (12) previously reported, besides twelve known compounds.  This is the first isolation of compounds 
15 – 19 from the Kankyo.  In addition, interestingly, two kinds of Kankyo are found to be sold in the Japanese 
market: one contains sulfonated derivatives and the other contains no such compound.
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INTRODUCTION
Shokyo and Kankyo (Japanese names of Zingiberis 
rhizome and Zingiberis  processum rhizome, 
respectively) are important crude drugs in traditional 
Kampo medicine made out of ginger, the rhizomes 
of Zingiber officinale ROSCOE (Zingiberaceae), by 
different process.  According to the Japanese Pharma-
copeia, Shokyo is prepared simply by drying, while 
Kankyo is by drying after steaming.  It is interest that 
the two crude drugs prepared from the same origin 
of ginger have been discriminated clinically use in 
Kampo medicine [1-3].  However there are no scien-
tific evidences for the clinical discrimination between 
Shokyo and Kankyo.  In order to clarify the chemical 
evidences for the discrimination between them, we 
started the studies on their chemical constituents.
We studied previously on the phytochemical in-
vestigation on Shokyo, and isolated, unexpectedly, 
six sulfonated compounds, i.e. 4- and 6-gingesulfonic 
acids (10), shogasulfonic acids A (12), B, C and D, 
together with gingerols, shogaols, diarylheptanoids 
[4] and five monoterpene glycosides, zingiberosides 
A, B, C, D and E [5].  Further on, we clarified that the 
sulfonated derivatives were artificial products formed 
by bleaching with sulfur in the preparation process [6], 
although the preparation procedure of Shokyo had 
been believed only drying without sulfur bleaching.
Kankyo is also prepared from ginger in almost 
same manner, only different process from Shokyo is 
prepared by steaming followed by drying as described 
above.  The constituents of Kankyo have been regard-
ed to be as the same as those of Shokyo, because their 
origins are same, and the previous investigations were 
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ed the configuration of 15 to be (3S,5S) [11].   Thus, 
15 was characterized as (3S,5S)-6-gingediol 4'-O-β-D-
glucopyranoside, which was previously isolated from 
the ginger rhizome [11]. 
Compound 16 was obtained as a pale yellowish oil, 
[α]16D  –11.0˚ (c 1.07, EtOH).  It showed a [M+H]
+ ion 
peak at m/z 407.2044 (C22H31O7) in the HR FAB-MS, 
which was 31 mass unit (CH3O) larger than that of 
hexahydrocurcumin (11) [12].  The IR spectrum of 14 
showed absorption bands due to hydroxyl group at 
3335 cm-1.  The feature of the 1H and 13C NMR spec-
tra of 16 were similar to those of 11, and they showed 
the presence of a β-glycol, a 1,3,4-trisubstituted ben-
zene ring, and a symmetrical 1,3,4,5-tetrasubstituted 
benzene ring having one hydroxyl group and two 
methoxyl groups in 11 (Table 1-1), suggesting 16 to 
be 3,5-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-
(4-hydroxy-3,5-dimethoxyphenyl)heptane.  Finally, 
16 was identified as (3S,5S)-3,5-dihydroxy-1-(4-hy-
droxy-3-methoxyphenyl) -7-(4-hydroxy-3,5- 
dimethoxyphenyl)-heptane by comparison of the data 
with those reported [13].
Compounds 17 and 18 were isolated as a pale yel-
lowish oily substance, and they showed the same 
[M+H]+ at m/z 391 in the Positive FAB-MS.  Their 
1H and 13C NMR spectra showed the presence of the 
same aromatic rings as 16, three oxymetine and four 
methylen groups, and their plane structures were sup-
posed to be 1,5-epoxy-3-hydroxy-1-(3,4-dihydroxy-5-
methoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)hep-
tane, which was recently isolated from the rhizome 
of ginger [10] (Table 1-1).  The H-3 signal of 17 was 
appeared as a dddd (J = 4.6, 4.6, 11.3 and 11.6 Hz) at 
δ 3.80, while that of 18 was as a dddd (J = 2.1, 2.1, 
2.8 and 2.8 Hz) at δ 4.21.  These facts demonstrated 
that the orientation of the C-3 hydroxyl group must be 
equatorial in 17 and axial in 18, that is, the structures 
of 17 and 18 were determined to be (1R,3S,5R)-1,5-
epoxy-3-hydroxy-1-(3,4-dihydroxy-5-methoxyphe-
resulted in isolation of the same components as those 
from Shokyo, volatile oils consist of sesquiterpenes 
of bisabolane-type and pungent constituents such as 
gingerols, shogaols and zingerone [7].
T h i s  p a p e r  d e a l s  w i t h  t h e  i s o l a t i o n  a n d 
characterization of nineteen compounds from the 80% 
methanol extract of Kankyo as well as the compara-
tive study on various Kankyo samples in the Japanese 
market. 
RESULTS AND DISCUSSION
The 80% methanol extract of commercial Kankyo 
A (imported from China, 5.0 kg) was divided into 
an ether- and a water-soluble fractions.  By means 
of column chromatography (CC) and HPLC, nine 
compounds (1 – 9) were isolated from the ether-
soluble fraction, and ten (10 – 19) were from the 
water-soluble fraction, as described in Experimental. 
Of them, the fourteen compounds were identified as 
follows by direct comparison with those obtained 
from Shokyo previously [4, 5] or by comparison of 
the data with those reported [8, 9]: 6-, 8-, 10-gingerols 
(1 – 3), 6-, 8-, 10-shogaols (4 – 6), 6-paradol (7), 
6-gingediacetate (8), zingerone (9), 6-gingesulfonic 
acid (10), hexahydrocurcumin (11), shogasulfonic 
acid A (12), zingiberosides A (13) and B (14), respec-
tively. 
Compound 15 was isolated as a white amorphous 
powder, mp 123 ˚C.  It showed a pseudomolecular ion 
([M+H]+) peak at m/z 459 (C23H39O9) in the FAB-MS. 
The 13C NMR spectrum of 15 revealed the presence 
of a 1,3,4-trisubstituted benzene, an arylic methoxyl 
group, two carbinyl methines, seven methylenes, an 
aliphatic methyl group and a β-D-glucopyranosyl 
moiety (Table 1-1).  The signals due to the aglycone 
part were resembled on those of 6-gingediol [8, 10], 
except for the C-4’ carbon signal due to the glycosyla-
tion shift.  In addition, an HMBC correlation was ob-
served between glucosyl H-1" (δ 4.82, d, J = 7.3 Hz) / 
C-4' (δ 146.1).  The specific rotation (–37.1˚) indicat-
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nyl)-7-(4-hydroxy-3-methoxyphenyl)heptane and 
(1R,3R,5R)-1,5-epoxy-3-hydroxy-1-(3,4-dihydroxy-
5-methoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)
heptane [14], or their enantiomer, respectively.
Compound 19 was obtained as a pale yellowish 
oily substance, and its HR FAB-MS showed a [M+H]+ 
ion peak at m/z 361.1647 (C20H25O6), which was 30 
mass unit smaller than that of 17 corresponding to 
loss of CH2O from 17.  The IR spectrum showed an 
absorption band at 3402 cm-1 due to hydroxyl group. 
The 13C NMR spectrum was very close to that of 17, 
but it showed the presence of another 4-hydroxy-
3-methoxyphenyl group instead of the 4-hydroxy-
3,5-dimethoxyphenyl group in 17, indicating the 
structure of 17 to be 1,5-epoxy-3-hydroxy-1-(3,4-
dihydroxy-5-methoxyphenyl)-7-(4-hydroxyphenyl)
heptane.  Whereas, the H-3 was observed a dddd (J = 
4.3, 4.6, 11.3 and 11.8 Hz) at δ 3.79, and the orienta-
tion of the C-3 hydroxyl group at must be equatorial. 
Thus, 19 was characterized as (1R,3S,5R)-1,5-epoxy- 
3-hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(4-
hydroxyphenyl)heptane [15] or its enantiomer.
The nineteen compounds were isolated from Kan-
kyo A, and their structures were characterized as 
mentioned above.  This is the first isolation of 10 – 
19 from Kankyo (Kankyo A in Experimental), and it 
is noteworthy that the sulfonated derivatives (10 and 
12) were also found as constituents of Kankyo, which 
had been believed to be prepared from ginger simply 
by steaming and then drying without sulfur bleaching. 
So that, this fact suggests that the sulfonated deriva-
tives must be artifacts caused by sulfur bleaching as 
previously reported on Shokyo [6], and that there 
would be two kinds of Kankyo in the Japanese mar-
ket: one is “genuine” Kankyo prepared from ginger, 
and another is “pseudo” Kankyo provably prepared 
from “sulfur-breached” ginger. 
While, we examined on another Kankyo (Kankyo 
B in Experimental), which was prepared in traditional 
way without sulfur breaching, and no sulfonated de-
rivatives have been obtained therefrom as its constitu-
ents [4, 6].  In addition to them, two compounds were 
isolated and identified as (1R,3S,5R)-1,5-epoxy-3-
hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(3,4-
dihydroxyphenyl)heptane (20) and (1R,3R,5R)-1,5-ep-
oxy- 3-hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-
7-(3,4-dihydroxyphenyl)heptane (21) or their 
enantiomers, respectively, based on coincidence of 
their data with those reported [15].
Further, we carried out additional examination on 
many samples of Shokyo and Kankyo collected in the 
Japanese market by means of TLC method.  As a re-
sult, sulfonated derivatives are contained in the almost 
every Shokyo samples, but in a half of Kankyo ones. 
On the other hand, the fresh ginger root contained no 
sulfonated derivatives as their constituents [6].
EXPERIMENTAL
General Procedures     Melting points were 
determined on a Yanaco micro-melting point 
apparatus (hot stage type) and were uncorrected. 
Optical rotations were carried on a JASCO DIP 140 
digital polarimeter.  IR spectra were measured on a 
JASCO FT/IR-410 spectrometer.  NMR spectra were 
recorded on a JEOL JNM LA-500 spectrometer (500 
MHz for 1H, 125 MHz for 13C) or JEOL JNM GX-400 
spectrometer (400 MHz for 1H, 100 MHz for 13C). 
Chemical shifts were given in a δ ppm scale from 
TMS used as an internal standard, and the signals 
were assigned by means of DEPT and 2D NMR 
techniques (1H-1H COSY, HMQC and HMBC).  MS 
spectra were obtained on a JEOL JMS SX-120A or 
JMS-700 spectrometer.  The matrix used for FAB-MS 
was shown in the parenthesis.  TLC was performed 
on a precoated silica gel 60 F254 or RP-18W F254 plate 
(Merck) and the detection was achieved by spray-
ing with 10% H2SO4 followed by heating.  Column 
chromatography was performed on silica gel 60 (< 45 
µm, Merck), Sephadex LH-20 (Pharmacia), or ODS 
(Chromatorex DM-1020T, Fuji-Silysia Co.).  
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acetone) and silica gel CC [Toluene-Acetone (3:1)] 
to give 11 (22 mg).  Fr. F4-3 was subjected to silica 
gel CC [CHCl3-MeOH (20:1)] and silica gel CC 
[Toluene-Acetone (3:2)] to give 16 (10 mg).  Fr. E 
was separated into four fractions by Sephadex LH-20 
CC (80% MeOH): Frs. E1 (0.9 g), E2 (6.1 g), E3 (0.5 
g) and E4 (50 mg).  Fr. E2 (1.0 g) was successively 
applied to silica gel CC [CHCl3-MeOH-AcOEt-
H2O (2:2:4:1), lower phase; CHCl3-MeOH-H2O 
(8:2:0.2)], Sephadex LH-20 CC (MeOH), and ODS 
CC (30% MeCN) to give 10 (17 mg).  Fr. E3 was 
chromatographed on silica gel CC [CHCl3-MeOH-
H2O (9:1:0.08)] to give five fractions: Frs. E3-1 (124 
mg), E3-2 (189 mg), E3-3 (84 mg), E3-4 (104 mg) 
and E3-5 (59 mg).  Fr. E3-2 was successively applied 
to ODS CC (45% MeOH) and HPLC (30% MeCN) 
to give 17 (32 mg) and 18 (10 mg).  Fr. E3-4 was 
subjected to ODS CC (30% MeCN) to give 19 (35 
mg).  Fr. D (10.0 g) was separated into three fractions 
by Sephadex LH-20 CC (MeOH): Frs. D1 (4.1 g), D2 
(6 g) and D3 (8 mg).  Fr. D2 was chromatographed on 
ODS CC with a gradient mixture of H2O and MeOH 
providing the following five fractions: Fr. D2-1 (25% 
MeOH, 1.5 g), D2-2 (25% MeOH, 627 mg), D2-3 
(25% MeOH, 534 mg), D2-4 (30% MeOH, 1.4 g) and 
D2-5 (30% MeOH, 1.9 g).  Fr. D2-4 was subjected to 
Sephadex LH-20 CC (MeOH) to give six fractions: 
Frs. D2-4-1 (190 mg), D2-4-2 (894 mg), D2-4-3 (193 
mg), D2-4-4 (12, 12 mg), D2-4-5 (7 mg) and D2-4-
6 (3 mg).  Fr. D2-4-2 was chromatographed on silica 
gel CC [CHCl3-MeOH-H2O (8:2:0.2, 7:3:0.5)] to give 
six fractions: D2-4-2a (96 mg), D2-4-2b (80 mg), D2-
4-2c (45 mg), D2-4-2d (365 mg), D2-4-2e (32 mg), 
D2-4-2f (264 mg).  Fr. D2-4-2d was successively 
applied to Sephadex LH-20 CC (MeOH) and ODS 
CC (10% MeOH) to give 13 (73 mg).  Fr. D2-4-2f 
was chromatographed on ODS CC (25% MeOH), 
and Sephadex LH-20 CC (MeOH) to give 12 (55 
mg).  Fr. D2-2 was successively applied to silica gel 
CC [CHCl3-MeOH-H2O (8:2:0.2, 7:3:0.5)], ODS CC 
(15% MeCN), Sephadex LH-20 CC (MeOH), silica 
Plant Material     Kankyo A (Lot. No. VMFNM: 
imported from China) was purchased from Uchida 
Wakanyaku Co., Ltd., Tokyo, Japan.  Kankyo B (Lot. 
No. 231001: imported from China) was purchased 
from Tochimoto-Tenkaido Co., Ltd., Osaka, Japan.
Extraction and Isolation     Powdered Kankyo 
A (5.0 kg) was percolated with 80% MeOH (37 L) 
at room temperature.  The 80% MeOH extract was 
concentrated in vacuo at 40 ˚C.  The residual syrup 
was suspended in H2O and extracted with ether 
(3 times) to afford an ether extract (164.5 g) after 
concentration to dryness.  The ether extract was 
chromatographed repeatedly on silica gel column 
chromatography (CC) [Hexane-Acetone (4:1)] and 
ODS CC (80% MeOH) to give nine compounds, 6-, 
8-, 10-gingerols (1 – 3), 6-, 8-, 10-shogaols (4 – 6), 
6-paradol (7), 6-gingediacetate (8), zingerone (9), 
identification of which were performed by direct 
comparison with their authentic samples isolated from 
Shokyo [4].  The aqueous layer (476.4 g) was, after 
concentration at 40 ˚C in vacuo, subjected to an ODS 
CC with a gradient mixture of H2O and MeOH pro-
viding the following eight fractions: Fr. A (H2O, 266.9 
g), B (H2O, 41.3 g), C (H2O, 10.5 g), D (50% MeOH, 
26.1 g), E (50% MeOH, 7.6 g), F (50% MeOH, 3.9 
g), G (50% MeOH, 2.2 g) and H (MeOH, 4.6 g).  Fr. 
F was separated into five fractions by Sephadex LH-
20 CC (MeOH): Frs. F1 (52 mg), F2 (1.5 g), F3 (1.6 
g), F4 (715 mg) and F5 (42 mg).  Fr. F3 was subjected 
to an ODS CC with a gradient mixture of H2O and 
MeOH providing the following five fractions: Frs. 
F3-1 (20% MeOH, 53.3 mg), F3-2 (30% MeOH, 114 
mg), F3-3 (30% MeOH, 55 mg), F3-4 (30% MeOH, 
1.07 g) and F3-5 (MeOH, 13 mg).  Fr. F3-2 was suc-
cessively applied to Sephadex LH-20 CC (MeOH) 
to give 10 (107 mg).  Fr. F4 (430 mg) was chro-
matographed on silica gel CC [CHCl3-MeOH-H2O 
(225:25:2)] to give six fractions: Frs. F4-1 (20 mg), 
F4-2 (77 mg), F4-3 (82 mg), F4-4 (19 mg), F4-5 (78 
mg) and F4-6 (121 mg).  Fr. F4-2 was successively 
applied to ODS (50% MeCN), Sephadex LH-20 (80% 
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gel CC [CHCl3-MeOH-H2O (7:3:0.5)], Sephadex LH-
20 CC (MeOH) and ODS CC (10% MeCN) to give 
14 (3 mg).  Fr. G was separated into two fractions by 
Sephadex LH-20 CC (MeOH): Frs. G1 (1.7 g) and 
G2 (188 mg).  Fr. G2 was successively applied to 
ODS (40% MeCN), Sephadex LH-20 (MeOH), silica 
gel [CHCl3-MeOH-H2O (8:2:0.2)], Sephadex LH-20 
(MeOH) and ODS CC (35% MeCN) to give 15 (15 
mg).
Powdered Kankyo B (5.0 kg) was also treated as in 
the case of Kankyo A: the ether extract (235 g) afford-
ed nine compounds, 1 – 9; the aqueous extract (241 g) 
gave 11, 13, 17 – 18, 20 – 21 [15].  But no sulfonated 
compounds (10 and 12) were obtained.
6-Gingesulfonic acid (10) [4]     White amorphous 
powder, mp. 177 – 181 ˚C, [α] 21D  + 0.7˚ (c 1.00, 
MeOH).  Positive FAB-MS (NBA) m/z: 359.1457 
[M+H]+ (Calcd for C17H27O6S: 359.1528).  IR νmax 
(KBr): 3182 (OH), 1711 (C=O), 1525 (benzene ring), 
1219, 1175, 1056 (SO3H) cm
-1.  These data were coin-
cident with those reported for 6-gingesulfonic acid 
[4].
Hexahydrocurcumin (11) [12]     Yellow oil, [α]17D  
+ 8.3˚ (c 0.29, CHCl3).  Positive FAB-MS (NBA), m/
z: 375.1815 [M+H]+ (Calcd for C21H27O6: 375.1808). 
The specific rotation of authentic hexahydrocurcumin 
was + 9.0˚, and the configuration of the 5-position of 
11 must be S [12].
Shogasulfonic acid A (12) [4]     Pale yellowish 
amorphous powder, mp. 205 ˚C, [α] 21D  – 0.5˚ (c 2.00, 
MeOH).  Positive FAB-MS (NBA) m/z: 439.1417 
[M+H]+ (Calcd for C21H27O8S: 439.1427).  EI-MS, m/
z: 356 ([M-H2SO3])
+).  IR νmax (KBr):  3379 (OH), 
1698 (C=O), 1523 (benzene ring), 1222, 1179, 1154, 
1054 (SO3H) cm
-1.  These data were coincident with 
those reported for Shogasulfonic acid A [4].
Zingiberoside A (13) [5]     White amorphous pow-
der, mp. 99 – 103 ˚C, [α]20D  – 18.4˚ (c 1.00, MeOH). 
Positive FAB-MS (NBA) m/z: 332.2064 [M+H]+ 
(Calcd for C16H27O7: 332.1835).  
Zingiberoside B (14) [5]     White amorphous pow-
der, mp. 123 ˚C, [α]21D  – 40.7˚ (c 1.27, MeOH).  Posi-
tive FAB-MS m/z: 495.2442 [M+H]+ (Calcd for 
C22H39O12: 495.2490).  
(3S,5S)-6-Gingerdiol 4’-O-β-D-glucopyranoside 
(15) [11]     White amorphous powder, mp. 123 ˚C, 
[α] 17D  – 37.1˚ (c 1.03, MeOH).  Positive FAB-MS 
(NBA) m/z: 459 [M+H]+ (Calcd for C23H39O9: 459). 
IR νmax (KBr): 3335 (OH), 2858 (OCH3), 1518 (ben-
zene ring) cm-1.  1H, 13C-NMR: Table 1-1.
( 3 S , 5 S ) - 3 , 5 - h y d r o x y - 1 - ( 4 - h y d r o x y - 3 -
methoxyphenyl)-7-(4-hydroxy-3,5-dimethoxy- 
phenyl)heptane (16) [13]     Yellow oil, [α]16D  – 11.0˚ 
(c 0.52, EtOH).  Positive FAB-MS (NBA) m/z: 
407.2044 [M+H]+ (Calcd for C22H31O7: 407.1992).  IR 
νmax (KBr): 3335 (OH), 2931, 2858 (OCH3), 1635, 
1515 (benzene ring) cm-1.  1H, 13C-NMR: Table 1-1.
(1R,3S,5R)-1,5-epoxy-3-hydroxy-1-(3,4-dihy-
d r o x y - 5 - m e t h o x y p h e n y l ) - 7 - ( 4 - h y d r o x y - 3 -
methoxyphenyl)heptane or its enantiomer (17) [14] 
Pale yellowish oil, [α]16D  – 65.2˚ (c 1.07, EtOH).  Posi-
tive FAB-MS (NBA) m/z: 391 [M+H]+ (Calcd for 
C21H27O7: 391).  IR νmax (KBr): 3397 (OH), 2941, 
2852 (OCH3), 1615, 1517 (benzene ring) cm
-1.  1H, 
13C-NMR: Table 1-1.
(1R,3R,5R)-1,5-Epoxy-3-hydroxy-1-(3,4-dihy-
d r o x y - 5 - m e t h o x y p h e n y l ) - 7 - ( 4 - h y d r o x y - 3 -
methoxyphenyl)heptane or its enantiomer (18) [14] 
Pale yellowish oil, [α]17D  – 56.5˚ (c 0.84, EtOH).  Posi-
tive FAB-MS (NBA) m/z: 391 [M+H]+ (Calcd for 
C21H27O7: 391).  IR νmax (KBr): 3339 (OH), 2927 
(OCH3), 1654, 1520 (benzene ring) cm
-1.  1H, 13C-
NMR: Table 1-1.
(1R,3S,5R)-1,5-Epoxy-3-hydroxy-1-(3,4-dihy-
droxy-5-methoxyphenyl)-7-(4-hydroxy-phenyl)
heptane or its enantiomer (19) [15]     Pale yellowish 
oil, [α] 15D  – 87.7˚ (c 1.28, EtOH).  Positive FAB-MS 
(NBA) m/z: 361.1647 [M+H]+ (Calcd for C20H25O6: 
361.1651).  IR νmax (KBr): 3402 (OH), 2853 (OCH3), 
1615, 1516 (benzene ring) cm-1.  1H, 13C-NMR: Table 
1-2.
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(1R,3S,5R)-1,5-Epoxy-3-hydroxy-1-(3,4-dihy-
droxy-5-methoxyphenyl)-7-(3,4-dihydroxyphenyl)
heptane (20) or its enantiomer [15]     Pale yellowish 
oil. [α]15D  – 58.3°(c 1.03, EtOH).  HR FAB-MS (NBA) 
m/z 377.1579 [M+H]+,  (Calcd for  C 20H 25O 7: 
377.1600).  IR νmax (KBr): 3398 (OH), 1618, 1524 
(benzene ring) cm-1.  1H and 13C NMR：Table 1-2.
(1R,3R,5R)-1,5-Epoxy-3-hydroxy-1-(3,4-dihy-
droxy-5-methoxyphenyl)-7-(3,4-dihydroxyphenyl)
heptane (21) or its enantiomer [15]     Pale yellowish 
oil. [α]15D  –31.0°(c 0.31, EtOH).  HR FAB-MS (NBA) 
m/z 377.1579 [M+H]+,  (Calcd for  C 20H 25O 7: 
377.1600).  IR νmax (KBr): 3398 (OH), 1618, 1524 
(benzene ring) cm-1.  1H and 13C NMR：Table 1-2.
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ショウガならびに関連薬物の生薬学的研究 (2) 
カンキョウ (乾姜) の成分
堀 由美子＊1，若林雪絵1，水井香代子1，福村基徳1，鳥居塚和生1，伊田喜光1,2
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要　旨
ショウガを基原とするカンキョウ (Zingiberis processum rhizome) の80% MeOH抽出エキスから
19種の化合物を単離した．これらは，既知化合物12種とgingerdiol 4'-O-β-D-glucopyranoside (15)，
4種のジアリルヘプタノイド類 (16 – 19)，既報のスルホン化誘導体：6-gingesulfonic acid (10) と 
shogasulfonic acid A (12) であった．このうち，15 – 19はカンキョウからは初めて得られた化合物で
ある．
また興味深いことに，本邦市場にはスルホン化誘導体を含むカンキョウと含まないカンキョウ
の2種類が存在することが分かった．
Key Words： ショウガ，ショウガ科，カンキョウ，Zingiberis processum rhizome, スルホン化誘導体
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